A panel of Food and Drug Administration experts voted to make the overdose-reversing drug naloxone available over the counter. Discussions centered on whether untrained users would be able
to safely and effectively use the nasal spray in emergency situations. "The positive vote, which is not binding, came despite concerns from some panel members about the drug’s instructions and
packaging, which caused confusion among some people in a company study," per The Associated Press. "The manufacturer, Emergent Biosolutions, said it would revise the packaging and labeling to address
those concerns. The FDA will make a final decision on the drug in coming weeks."
Read the whole story at The Associated Press »